Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical course and significance of the novel FLT3-Y842C mutation in a patient with AML treated with PKC412 monotherapy
    Meeting Abstract

    Kindler, T.; Breitenbuecher, F.; Kasper, S.; Estey, E.; Giles, F.; Feldman, E.; Ehninger, G.; Schiller, G.; Klimek, V.; Nimer, S. D.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Selective depletion of T cell clones responsible for GVHD in a murine model
    Meeting Abstract

    Kappel, B. J.; Eng, J. M.; Pinilla-Ibarz, J.; van den Brink, M. R. M.; Scheinberg, D. A.
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • Tositumomab and iodine I 131 tositumomab (The BEXXAR (R) therapeutic regimen) produced ongoing, durable remissions of more than 5 years in 9 patients with non-Hodgkin's lymphoma (NHL) in a pivotal study of patients refractory to their last chemotherapy
    Meeting Abstract

    Kaminski, M. S.; Zelenetz, A. D.; Press, O. W.; Saleh, M. N.; Leonard, J. P.; Fehrenbacher, L.; Lister, T. A.; Kroll, S.; Wahl, R. L.; Knox, S. J.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Phase II trials of clofarabine in relapsed or refractory pediatric leukemia
    Meeting Abstract

    Jeha, S.; Razzouk, B. I.; Ryttin, M. E.; Gaynon, P. S.; Kadota, R.; Rheingold, S.; Luchtman-Jones, L.; Shen, V.; Arceci, R. J.; Fernandez, M.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Clofarabine therapy for the treatment of relapsed or refractory pediatric acute leukemias
    Meeting Abstract

    Jeha, S.; Razzouk, B.; Gaynon, P.; Kadota, R.; Rheingold, S.; Luchtman-Jones, L.; Arceci, R.; Fernandez, M.; Weitman, S.; Steinherz, P.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Absence of inducible costimulator (ICOS) on alloreactive T cells reduces graft-versus-host-disease while leaving graft-versus-tumor activity intact
    Meeting Abstract

    Hubbard, V. M.; Eng, J. M.; Tjoe, K. H.; Ramirez-Montagut, T.; Muriglan, S. J.; Kochman, A. A.; Terwey, T. H.; Schiro, R.; Alpdogan, O.; van den Brink, M. R. M.
    Blood (2004)

    Fulltext@MSK | Save
  • AML patients lacking KIR ligand for donor KIR exhibit increased overall survival in HLA-identical sibling transplants
    Meeting Abstract

    Hsu, K. C.; Taylor, C. A.; O'Reilly, R. J.; Horowitz, M. M.; Arkun, K.; Pinto, C.; Dupont, B.
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • Mechanisms of resistance to the FLT3-tyrosine kinase inhibitor PKC412 in patients with AML
    Meeting Abstract

    Heidel, F.; Breitenbuecher, F.; Kindler, T.; Solem, F. K.; Carius, B.; Thiede, H. M.; Cohen, P. S.; Roesel, J.; Estey, E. H.; Feldman, E.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone followed by thalidomide and dexamethasone (AD-TD) as initial therapy for symptomatic patients with multiple myeloma
    Meeting Abstract

    Hassoun, H.; Reich, L.; Klimek, V. M.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Zimman, R.; Hedvat, C. V.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Evaluation of an intensity modulated radiation therapy treatment technique for patients with medulloblastoma
    Meeting Abstract

    Happersett, L.; Hunt, M.; Wolden, S.; Goodman, K.; Hong, L.; Chui, C.
    International Journal of Radiation Oncology, Biology, Physics (2004)

    Fulltext@MSK | Save